関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | L-tert-Leucine | HCID 164608 | — |
| 反応物 | Sodium borohydride | HCID 4311764 | — |
| 反応物 | 1,5-Benzothiazepine-3,4(2H,5H)-dione, 2-(4-methoxyphenyl)- | HCID 10902623 | — |
| 溶媒 | Tetrahydrofuran | HCID 8028 | — |
| 生成物 | 3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one, (2S,3S)- | HCID 2733673 | — |
反応手順
A reducing agent is prepared in the same manner as in Example 9 from a mixture of L-tert-leucine (721 mg), sodium borohydride (189 mg) and tetrahydrofuran (50 ml), and the reaction mixture is cooled to -15° C. To the mixture is added 2-(4-methoxyphenyl)-1,5-benzothiazepine-3,4(2H,5H)-dione (997 mg), and the acid listed in the following Table 1 is added thereto at 30 minutes and 2 hours thereafter (totality: 3.33 mmole), and the reaction is carried out at the same temperature. After confirming by HPLC that the starting compound is completely consumed, the mixture is treated in the same manner as in Example 9 to give (2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one. The yield, optical purity of the cis-compound and content of the trans-compound are as shown in the following Table 1.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US05310904 |
|---|
| 出典データセット | uspto-grants-1994_05 |
|---|
| ORD ID | ord-0fc81575510942588d1d5ba6fcd4de7b |
|---|
| 出典メモ | uspto-grants-1994_05 |
|---|